| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cetirizine | FAERS: 2 | US FAERS | |
| 2 | Cetirizine | FAERS: 2 | US FAERS | |
| 3 | Oxcarbazepine | FAERS: 2 | US FAERS | |
| 4 | Paroxetine | FAERS: 2 | US FAERS | |
| 5 | Citalopram | FAERS: 1 | US FAERS | |
| 6 | Levetiracetam | FAERS: 1 | US FAERS | |
| 7 | Lopinavir | FAERS: 1 | US FAERS | |
| 8 | Pregabalin | FAERS: 1 | US FAERS | |
| 9 | fexofenadine | FAERS: 1 | US FAERS | |
| 10 | iopromide | FAERS: 1 | US FAERS | |
| 11 | Chlorothiazide | OFFSIDES | ||
| 12 | Piperacillin, Tazobactam Drug Combination | OFFSIDES | ||
| 13 | Vigabatrin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.